Literature DB >> 32269634

ZNF24 is upregulated in prostate cancer and facilitates the epithelial-to-mesenchymal transition through the regulation of Twist1.

Xiangjiang Huang1,2, Nanxin Liu1,2, Xing Xiong1,2.   

Abstract

Zinc finger protein 24 (ZNF24) has been demonstrated to regulate proliferation, differentiation and migration as well as invasion in several types of cells. However, the molecular role and clinical effects of ZNF24 in prostate cancer (PCa) remain unclear. The present study revealed that ZNF24 expression is upregulated in PCa, and associated with tumor volume, Gleason score, pathological grade and metastasis. Wound healing and Transwell invasion assays revealed that ectopic ZNF24 expression facilitated cell migration and invasion through the Twist1-induced epithelial-to-mesenchymal transition (EMT) process. In addition, colony formation and Cell Counting Kit-8 assays were used to determine the regulatory effects of ZNF24 on proliferation. The results suggested that ZNF24 also promoted cell proliferation in PCa. ZNF24 acted as an oncogene and promoted migration, invasion and EMT of PCa cells via the regulation of Twist1.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  Twist1; epithelial-to- mesenchymal transition; invasion; prostate cancer; zinc finger protein 24

Year:  2020        PMID: 32269634      PMCID: PMC7115158          DOI: 10.3892/ol.2020.11456

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Epithelial-mesenchymal transitions in development and pathologies.

Authors:  Jean Paul Thiery
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

Review 3.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

4.  Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study.

Authors:  K Shafique; M J Proctor; D C McMillan; K Qureshi; H Leung; D S Morrison
Journal:  Prostate Cancer Prostatic Dis       Date:  2011-11-29       Impact factor: 5.554

Review 5.  Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation.

Authors:  Dianbo Yao; Chaoliu Dai; Songlin Peng
Journal:  Mol Cancer Res       Date:  2011-08-12       Impact factor: 5.852

6.  Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Mark K Buyyounouski; Peter L Choyke; Jesse K McKenney; Oliver Sartor; Howard M Sandler; Mahul B Amin; Michael W Kattan; Daniel W Lin
Journal:  CA Cancer J Clin       Date:  2017-02-21       Impact factor: 508.702

7.  Lipocalin 2 promotes breast cancer progression.

Authors:  Jiang Yang; Diane R Bielenberg; Scott J Rodig; Robert Doiron; Matthew C Clifton; Andrew L Kung; Roland K Strong; David Zurakowski; Marsha A Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

8.  Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells.

Authors:  Xianghong Wang; Ming Tat Ling; Xin-Yuan Guan; Sai Wah Tsao; Hiu Wing Cheung; Davy Tak Lee; Yong Chuan Wong
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

9.  Zinc finger protein 191 deficiency attenuates vascular smooth muscle cell proliferation, migration, and intimal hyperplasia after endovascular arterial injury.

Authors:  Lei Lv; Jiwei Zhang; Peng Wang; Qiurong Meng; Wei Liang; Lan Zhang
Journal:  J Vasc Surg       Date:  2013-06-04       Impact factor: 4.268

10.  Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.

Authors:  Akash Kumar; Ilsa Coleman; Colm Morrissey; Xiaotun Zhang; Lawrence D True; Roman Gulati; Ruth Etzioni; Hamid Bolouri; Bruce Montgomery; Thomas White; Jared M Lucas; Lisha G Brown; Ruth F Dumpit; Navonil DeSarkar; Celestia Higano; Evan Y Yu; Roger Coleman; Nikolaus Schultz; Min Fang; Paul H Lange; Jay Shendure; Robert L Vessella; Peter S Nelson
Journal:  Nat Med       Date:  2016-02-29       Impact factor: 53.440

View more
  3 in total

1.  A Novel Tumor Suppressor Gene, ZNF24, Inhibits the Development of NSCLC by Inhibiting the WNT Signaling Pathway to Induce Cell Senescence.

Authors:  Bo Pang; Yong Wang; Xiaoyan Chang
Journal:  Front Oncol       Date:  2021-07-27       Impact factor: 5.738

2.  CASP9 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Inflammatory Breast Cancer.

Authors:  Mingdi Zhang; Kejin Wu; Maoli Wang; Fang Bai; Hongliang Chen
Journal:  Int J Anal Chem       Date:  2022-09-25       Impact factor: 1.698

3.  The Novel Tumor Suppressor Gene ZNF24 Induces THCA Cells Senescence by Regulating Wnt Signaling Pathway, Resulting in Inhibition of THCA Tumorigenesis and Invasion.

Authors:  Juan Xiong; Panpan Jiang; Li Zhong; Youling Wang
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.